Pacific Biosciences Of California (PACB) Other Accumulated Expenses (2011 - 2026)

Pacific Biosciences Of California's Other Accumulated Expenses history runs 16 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 77.83% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (down 77.83% YoY), while the FY2025 annual figure was $2.0 million, down 37.0% from the prior year.
• Other Accumulated Expenses was $1.2 million for Q1 2026 at Pacific Biosciences Of California, down from $2.0 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $8.3 million in Q4 2023 to a low of $783000.0 in Q3 2024.
• Historically, Other Accumulated Expenses has averaged $4.3 million across 5 years, with a median of $4.6 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Other Accumulated Expenses surged 103.31% in 2022, then plunged 84.85% in 2024.
• A 5-year view of Other Accumulated Expenses shows it stood at $7.2 million in 2022, then gained by 15.11% to $8.3 million in 2023, then slumped by 61.28% to $3.2 million in 2024, then slumped by 37.0% to $2.0 million in 2025, then plunged by 39.19% to $1.2 million in 2026.
• The last three Other Accumulated Expenses figures came in at $1.2 million (Q1 2026), $2.0 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.